Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project.

Moser B, Fadel E, Fabre D, Keshavjee S, de Perrot M, Thomas P, Brioude G, Van Raemdonck D, Viskens S, Lang-Lazdunski L, Bille A, Weder W, Jungraithmayr W, Ruffini E, Guerrera F, Gómez de Antonio D, Liberman M, Novoa N, Scarci M, Janik S, Klepetko W.

Eur J Cardiothorac Surg. 2017 Apr 25. doi: 10.1093/ejcts/ezx090. [Epub ahead of print]

PMID:
28449028
2.

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.

Bayman N, Ardron D, Ashcroft L, Baldwin DR, Booton R, Darlison L, Edwards JG, Lang-Lazdunski L, Lester JF, Peake M, Rintoul RC, Snee M, Taylor P, Lunt C, Faivre-Finn C.

BMJ Open. 2016 Jan 27;6(1):e010589. doi: 10.1136/bmjopen-2015-010589.

3.

Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.

Leuzzi G, Rocco G, Ruffini E, Sperduti I, Detterbeck F, Weder W, Venuta F, Van Raemdonck D, Thomas P, Facciolo F; ESTS Thymic Working Group.

J Thorac Cardiovasc Surg. 2016 Jan;151(1):47-57.e1. doi: 10.1016/j.jtcvs.2015.08.034. Epub 2015 Aug 15.

PMID:
26403869
4.

Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.

Lang-Lazdunski L, Bille A, Papa S, Marshall S, Lal R, Galeone C, Landau D, Steele J, Spicer J.

J Thorac Cardiovasc Surg. 2015 Feb;149(2):558-65; discussion 565-6. doi: 10.1016/j.jtcvs.2014.10.041. Epub 2014 Oct 14.

5.

Invited commentary.

Lang-Lazdunski L.

Ann Thorac Surg. 2015 Feb;99(2):481. doi: 10.1016/j.athoracsur.2014.10.006. No abstract available.

PMID:
25639393
6.

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors.

Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Lucchi M, Marino M, Marom EM, Nicholson AG, Ruffini E; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain.

J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S81-7. doi: 10.1097/JTO.0000000000000291.

7.

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors.

Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain.

J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S73-80. doi: 10.1097/JTO.0000000000000303.

8.

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors.

Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Frazier AA, Giaccone G, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Ruffini E, Van Schil P; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain.

J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S65-72. doi: 10.1097/JTO.0000000000000290.

9.

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.

Rintoul RC, Ritchie AJ, Edwards JG, Waller DA, Coonar AS, Bennett M, Lovato E, Hughes V, Fox-Rushby JA, Sharples LD; MesoVATS Collaborators.

Lancet. 2014 Sep 20;384(9948):1118-27. doi: 10.1016/S0140-6736(14)60418-9. Epub 2014 Jun 16.

PMID:
24942631
10.

Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database.

Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, Brunelli A, Guerrera F, Keshavjee S, Altorki N, Schützner J, Arame A, Spaggiari L, Lim E, Toker A, Venuta F; European Society of Thoracic Surgeons Thymic Working Group.

J Thorac Oncol. 2014 Apr;9(4):541-8. doi: 10.1097/JTO.0000000000000128.

11.

Thoracotomy and decortication: impact of culture-positive empyema on the outcome of surgery.

Okiror L, Coltart C, Bille A, Guile L, Pilling J, Harrison-Phipps K, Routledge T, Lang-Lazdunski L, Hemsley C, King J.

Eur J Cardiothorac Surg. 2014 Nov;46(5):901-6. doi: 10.1093/ejcts/ezu104. Epub 2014 Mar 14.

PMID:
24634483
12.

Surgery for malignant pleural mesothelioma: why, when and what?

Lang-Lazdunski L.

Lung Cancer. 2014 May;84(2):103-9. doi: 10.1016/j.lungcan.2014.01.021. Epub 2014 Feb 3. Review.

PMID:
24602395
13.

Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database.

Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, Brunelli A, Evangelista A, Venuta F; European Association of Thoracic Surgeons (ESTS) Thymic Working Group.

Eur J Cardiothorac Surg. 2014 Sep;46(3):361-8. doi: 10.1093/ejcts/ezt649. Epub 2014 Jan 30.

14.

The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies.

Detterbeck FC, Asamura H, Crowley J, Falkson C, Giaccone G, Giroux D, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson A, Okumura M, Ruffini E, van Schil P, Stratton K; Staging and Prognostic Factors Committee; Members of the Advisory Boards; Participating Institutions of the Thymic Domain.

J Thorac Oncol. 2013 Dec;8(12):1467-73. doi: 10.1097/JTO.0000000000000017.

15.

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.

Lüchtenborg M, Riaz SP, Lim E, Page R, Baldwin DR, Jakobsen E, Vedsted P, Lind M, Peake MD, Mellemgaard A, Spicer J, Lang-Lazdunski L, Møller H.

Thorax. 2014 Mar;69(3):269-73. doi: 10.1136/thoraxjnl-2013-203884. Epub 2013 Oct 30.

16.

The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma.

Klabatsa A, Chicklore S, Barrington SF, Goh V, Lang-Lazdunski L, Cook GJ.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):276-82. doi: 10.1007/s00259-013-2561-1. Epub 2013 Sep 21.

PMID:
24057459
17.

Surgery for nonsmall cell lung cancer.

Lang-Lazdunski L.

Eur Respir Rev. 2013 Sep 1;22(129):382-404. doi: 10.1183/09059180.00003913. Review.

18.

Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.

Bille A, Chicklore S, Okiror L, Cook GJ, Spicer J, Landau D, Lang-Lazdunski L.

Nucl Med Commun. 2013 Nov;34(11):1075-83. doi: 10.1097/MNM.0b013e3283653862.

PMID:
23963351
19.

Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy.

Papa S, Popat S, Shah R, Prevost AT, Lal R, McLennan B, Cane P, Lang-Lazdunski L, Viney Z, Dunn JT, Barrington S, Landau D, Spicer J.

J Thorac Oncol. 2013 Jun;8(6):783-7. doi: 10.1097/JTO.0b013e31828c2b26.

20.

The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H, Weder W, Sugarbaker DJ; participants in 2012 International Mesothelioma Interest Group Congress.

J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-10. doi: 10.1016/j.jtcvs.2013.01.039. Epub 2013 Feb 14. No abstract available.

Supplemental Content

Loading ...
Support Center